Order results by:
| Issue | Title | |
| Vol 16, No 2 (2024) | Efficacy of antiparkinsonian therapy in tremor correction according to tremorography | Abstract similar documents |
| V. A. Bogacheva, D. V. Zakharov, V. A. Mikhailov | ||
| "... , and the efficacy of pramipexole in treating tremor was comparable to that of levodopa in the early stages ..." | ||
| Vol 16, No 3 (2024) | Isolated head tremor | Abstract similar documents |
| Z. A. Zalyalova, M. M. Ermakova, Z. G. Khayatova | ||
| "... Isolated head tremor (IHT) is a pathological condition characterized by tremor of the head without ..." | ||
| Vol 14, No 2 (2022) | Drug-induced tremor | Abstract similar documents |
| T. M. Ostroumova, V. A. Tolmacheva, O. D. Ostroumova | ||
| "... Drug-induced tremor (DIT) is a term used to describe tremors that develop or increase in severity ..." | ||
| Online-first | Features of pathogenesis and clinical manifestation of Parkinson's disease developed from essential tremor | Abstract similar documents |
| A. V. Kudrevatykh, I. V. Miliukhina | ||
| "... tremor (ET). In addition, PD often develops when patient already suffers from ET. Today, the problem ..." | ||
| Vol 11, No 3 (2019) | The features of the pathogenesis and clinical picture of Parkinson's disease that has developed in essential tremor | Abstract similar documents |
| A. V. Kudrevatykh, I. V. Miliukhina | ||
| "... ) and essential tremor (ET). In addition, PD frequently develops in already existing ET. The occurrence of PD ..." | ||
| Vol 9, No 4 (2017) | The course of cervical dystonia with head tremor during botulinum toxin type A treatment | Abstract similar documents |
| A. N. Korenko, A. A. Skoromets, A. A. Timofeeva, A. V. Tishkov | ||
| "... into the neck muscles to reduce dystonic postures, head tremor, and pain syndrome in patients with cervical ..." | ||
| Vol 11, No 1 (2019) | Functional movement disorders: positive diagnostic criteria | Abstract similar documents |
| E. О. Ivanova, E. Yu. Fedotova | ||
| "... and instrumental diagnostic criteria and presents the neurophysiological characteristics of functional tremor ..." | ||
| Vol 14, No 6 (2022) | A “new” role of amantadines in COVID-19 in patients with Parkinson’s disease: results of own comparative study | Abstract similar documents |
| Z. A. Zalyalova, S. E. Munasipova, D. M. Khasanova, G. R. Ilyina, Z. G. Khayatova, N. I. Bagdanova | ||
| "... : the appearance or increase in motor fluctuations (41%), increased tremor, stiffness or slowness (31 ..." | ||
| Vol 4, No 2 (2012) | Capacities of the dopamine receptor agonist pramipexole in the treatment of patients with Parkinson’s disease | Abstract similar documents |
| S N Illarioshkin | ||
| "... Dopaminergic stimulation with levodopa, a biological precursor of dopamine precursor, and dopamine ..." | ||
| Vol 6, No 3 (2014) | Current therapy for Parkinson's disease | Abstract similar documents |
| A. V. Obukhova | ||
| "... in the nigrostriatal system. Levodopa preparations and dopamine receptor agonists (DRAs) that are prescribed ..." | ||
| Vol 7, No 3 (2015) | Experience in using levodopa-benserazide | Abstract similar documents |
| Elena Anatolyevna Katunina, Yu. N. Bezdolnyi, E. A. Malykhina, N. V. Titova | ||
| "... Levodopa remains the most effective drug for the treatment of Parkinson's disease. The paper ..." | ||
| Vol 15, No 3 (2023) | Parkinson’s disease. Focus on early stages | Abstract similar documents |
| E. A. Katunina, Z. A. Zalyalova, D. V. Pokhabov, M. Z. Ivanova, A. M. Semenova | ||
| "... motor manifestations occur: hypokinesia, rest tremor, muscle rigidity. Substantia nigra ultrasound ..." | ||
| Vol 12, No 1 (2020) | Pharmacogenetics of drug-induced dyskinesias in Parkinson's disease | Abstract similar documents |
| A. A. Tappakhov, T. E. Popova, T. G. Govorova, N. A. Shnaider, M. R. Sapronova | ||
| "... Levodopa remains the gold standard of treating Parkinson's disease (PD). However, the inevitable ..." | ||
| Vol 17, No 3 (2025) | Parkinson's disease and migraine | Abstract similar documents |
| Z. A. Zalyalova, E. A. Katunina, D. V. Pokhabov | ||
| Vol 15, No 5 (2023) | The phenomenon of “visual snow”: clinical and pathophysiological correlations, differential diagnosis and treatment (literature review) | Abstract PDF (Eng) similar documents |
| A. S. Kamaeva, E. A. Kiryanova, G. R. Tabeeva | ||
| "... symptoms as well as tinnitus, migraine, dizziness, tremor, fibromyalgia, paresthesias, depersonalization ..." | ||
| Vol 15, No 3 (2023) | Vitamin B12 deficiency and Parkinson’s disease | Abstract similar documents |
| Z. A. Zalyalova, E. V. Ekusheva | ||
| "... with levodopa (especially its intraduodenal administration), as well as clinical manifestations ..." | ||
| Vol 5, No 3 (2013) | The efficacy of the dopamine agonist Rotigotine in the treatment of Parkinson's disease | Abstract similar documents |
| Marina Romanovna Nodel | ||
| "... and in combination with levodopa in late-stage PD and in inadequate morning motor control despite antiparkinsonian ..." | ||
| Vol 15, No 6 (2023) | Effect of dopaminergic therapy on lacrimation in Parkinson's disease | Abstract similar documents |
| A. A. Pilipovich, O. V. Vorob'eva, S. A. Makarov, A. V. Kuchuk | ||
| "... to Hoehn and Yahr (H&Y) receiving therapy with levodopa (n=17), amantadines (n=13) and dopamine receptor ..." | ||
| Vol 12, No 6 (2020) | Cerebral glucose metabolism and cognitive impairment in tremor-dominant and akinetic-rigid subtypes of Parkinson’s disease | Abstract similar documents |
| I. V. Miliukhina, Yu. G. Khomenko, E. V. Gracheva, G. V. Kataeva, E. A. Gromova | ||
| "... . The akinetic-rigid (AR) and tremor-dominant (TD) types of PD differ not only in motor manifestations, but also ..." | ||
| Vol 7, No 2 (2015) | Dizziness in stroke | Abstract similar documents |
| M. V. Zamergrad | ||
| "... . However, intention tremor in fingernose and heel-knee tests on the left side, a negative Halmagyi test ..." | ||
| Vol 13, No 3 (2021) | Profile and frequency of antiparkinsonian drugs adverse reactions: a systematic review and meta-analysis | Abstract similar documents |
| A. A. Tappakhov, T. E. Popova, A. I. Vasilev, T. G. Govorova, Yu. I. Khabarova, K. A. Timofeeva, N. A. Schnaider | ||
| "... (OR) and 95% confidence interval (95% CI) calculation. Results and discussion. Levodopa/benserazide (LB) had ..." | ||
| Vol 3, No 1 (2011) | Sleep disorders in Parkinson's disease | Abstract similar documents |
| M. R. Nodel | ||
| "... in the severity of motor (hypokinesis, rigidity, tremor, nocturnal and morning dystonia) and nonmotor (restless ..." | ||
| Vol 17, No 2 (2025) | Drug-induced dyskinesia when taking Fluvoxamine | Abstract similar documents |
| A. A. Katok, D. M. Khasanova, I. A. Khasanov | ||
| "... of developing adverse phenomena such as dystonia and tremor. This emphasizes the need for careful monitoring ..." | ||
| Vol 6, No 4 (2014) | Dopaminergic deficiency syndrome in the picture of severe brain injury in the presence of protracted depression of consciousness | Abstract similar documents |
| M. V. Chelyapina, E. V. Sharova, O. S. Zaitsev | ||
| "... a constellation of neurological symptoms as increased extrapyramidal muscle tone, resting tremor, and specific ..." | ||
| Vol 2, No 3 (2010) | Russian observational study of the efficacy and tolerability of depakine chrono as first-line monotherapy for focal epilepsy | Abstract similar documents |
| E. D. Belousova | ||
| "... /1580), and tremor in 1.5% (25/1580). Conclusion. The study indicates that the use of sustained-release ..." | ||
| Vol 12, No 6 (2020) | Efficacy and safety of antipsychotics in adolescents with an acute psychotic episode in relation to the activity of CYP3A and CYP2D6 isoenzymes | Abstract similar documents |
| D. V. Ivashchenko, A. S. Osipov, E. V. Nazarova, M. A. Ovchinnikova, N. I. Buromskaya, V. V. Smirnov, P. V. Shimanov, R. V. Deitch, T. A. Fainshtein, E. N. Shagovenko, K. A. Akmalova, A. A. Kachanova, E. A. Grishina, L. M. Savchenko, Yu. S. Shevchenko, D. A. Sychev | ||
| "... with tremor (0.54 [0.34; 1.34] vs 1.25 [0.91; 1.75]; p=0.023). Also, patients with any documented adverse ..." | ||
| Vol 9, No 1S (2017): SPECIAL ISSUE: EPILEPSY | The efficacy and safety of valproic acid medications with controlled active ingredient release in adults in real clinical practice from the position of pharmacokinetic and pharmacogenetic approaches | Abstract similar documents |
| P. N. Vlasov, N. V. Orekhova, M. V. Antonyuk, N. V. Filatova, N. A. Schnaider, D. V. Dmitrenko, S. N. Zobova, I. E. Poverennova, A. V. Yakunina, V. A. Kalinin, S. K. Zyryanov, I. F. Tishchenkova | ||
| "... , tremor, and hair loss; however, their total frequency (16%) proved to be substantially lower than ..." | ||
| Vol 4, No 3 (2012) | Clinical experience with requip modutab | Abstract similar documents |
| Denis Valeryevich Zakharov, V A Mikhailov | ||
| "... are recommended as the drugs of choice as monotherapy and in combination with levodopa to enhance the efficiency ..." | ||
| Vol 5, No 1 (2013) | Dopamine dysregulation syndrome in Parkinson’s disease | Abstract similar documents |
| A V Nikitina, Natalia Vladimirovna Fedorova | ||
| "... , the quality-of-life indicators ranged from 19.8 to 90% (54+20.1%). The equivalent dose of levodopa is 1323 ..." | ||
| Vol 10, No 2 (2018) | Parkinson's disease and polymorphisms of the glutamatergic system genes GRIN2A, SLC1A2, and GRIK4 | Abstract similar documents |
| Yu. S. Mironova, I. A. Zhukova, N. G. Zhukova, S. A. Ivanova, V. M. Alifirova, A. S. Boiko, D. Z. Osmanova, O. P. Izhboldina, A. V. Latypova | ||
| "... . In the group of patients with tremor-dominant PD, the GRIK4 polymorphism rs1954787 showed a considerable ..." | ||
| Vol 13, No 2 (2021) | Drug-induced hypersomnia | Abstract PDF (Eng) similar documents |
| T. M. Ostroumova, O. D. Ostroumova, A. V. Filippova, T. F. Guseva | ||
| "... . Most often, the development of DIH is associated with the use of levodopa-carbidopa, antipsychotics ..." | ||
| Vol 7, No 4 (2015) | Some aspects of treatment for cognitive impairments. Cyticolin: pharmacological characteristics, possible benefits, aspects of use | Abstract similar documents |
| N. V. Trofimova, I. S. Preobrazhenskaya | ||
| "... and to delay of loss of the therapeutic effects of levodopa preparations. Cyticolin has been noted to have ..." | ||
| Vol 10, No 4 (2018) | Nighttime sleep disorders in patients with daytime sleepiness in Parkinson s disease | Abstract similar documents |
| M. R. Nodel, K. V. Shevtsova, G. V. Kovrov, N. N. Yakhno | ||
| "... with levodopa at a mean daily dose of 667.8 mg; 98 of them had the drug in combination with dopamine receptor ..." | ||
| Vol 9, No 3 (2017) | Screening for non-motor symptoms in Parkinson's disease using the NMSQuest scale | Abstract similar documents |
| A. A. Tappakhov, T. E. Popova, T. Ya. Nikolaeva, N. A. Schnaider, M. M. Petrova | ||
| "... with reference to levodopa). Conclusion. The use of questionnaires in patients with PD allows the timely ..." | ||
| Vol 5, No 1 (2013) | Practical aspects of the use of extended-release ropinirole (requip modutab) in the treatment of Parkinson’s disease | Abstract similar documents |
| Oleg Semenovich Levin, V K Datiyeva | ||
| "... of levodopa or to be limited to its minimal dose, on the other hand, reducing the risk of fluctuations ..." | ||
| 1 - 35 of 35 Items | ||
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
